Could this shot train your body to handle peanuts?

NCT ID NCT07349212

Not yet recruiting Disease control Sponsor: Ukko Inc Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new injection called UKK-0018 in adults with peanut allergies. The goal is to see if the treatment is safe and if it can help the immune system become less reactive to peanuts over time. Researchers will give the injections to 40 participants and measure their ability to tolerate peanut protein in food challenges.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEANUT ALLERGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Pacific Clinical Research Network

    Auckland, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Royal Melbourne Hospital

    Fitzroy, Victoria, 3065, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.